Human medicines European public assessment report (EPAR): Komboglyze, saxagliptin / metformin hydrochloride, Diabetes Mellitus, Type 2, Date of authorisation: 24/11/2011, Revision: 15, Status: Authorised

Case Medical Research ◽

10.31525/cmr-58722c ◽

2018 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Qtrilmet, metformin hydrochloride / saxagliptin / dapagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-23f0dba ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin / metformin, Diabetes Mellitus, Type 2, Date of authorisation: 30/11/2008, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-57f559 ◽

2018 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin / metformin, Diabetes Mellitus, Type 2, Date of authorisation: 30/11/2008, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-5871da ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Qtrilmet, metformin hydrochloride / saxagliptin / dapagliflozin, Diabetes Mellitus, Type 2, Date of authorisation: 11/11/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-23ef88d ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Jentadueto, linagliptin / metformin hydrochloride, Diabetes Mellitus, Type 2, Date of authorisation: 19/07/2012, Revision: 15, Status: Authorised

Case Medical Research ◽

10.31525/cmr-191b08c ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Segluromet, ertugliflozin / metformin hydrochloride, Diabetes Mellitus, Type 2, Date of authorisation: 23/03/2018, Revision: 2, Status: Authorised

Case Medical Research ◽

10.31525/cmr-17404af ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ristfor, sitagliptin / metformin hydrochloride, Diabetes Mellitus, Type 2, Date of authorisation: 15/03/2010, Revision: 19, Status: Authorised

Case Medical Research ◽

10.31525/cmr-12043f2 ◽

2019 ◽

Author(s):

Keyword(s):

Diabetes Mellitus ◽

Diabetes Mellitus Type 2 ◽

Diabetes Mellitus Type ◽

Metformin Hydrochloride ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text